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INTRODUCTION
Otitis media with effusion (OME) is an inflammatory disorder 
of the middle ear that is characterised by the presence of endo-
tympanic fluid without any sign or symptom of acute ear infec-
tion [1], which may lead to hearing loss (HL) or long-term se-
quelae and have a negative impact on speech development and 
behaviour [1-3]. It is estimated that up to 90% of children expe-
rience at least one episode before reaching school age (60% of 
the episodes occur in the first 2 years of life) [1,2], and that a to-
tal of 2.2 million pediatric episodes a year are diagnosed in the 
United States alone. 
 Given the low rate of spontaneous resolutions (<30% in chil-
dren aged <4 years) [3] and the ineffectiveness of medical treat-
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Objectives. Surgical management of children with chronic otitis media with effusion (OME) includes tympanostomy tube 
insertion or adenoidectomy, alone or with myringotomy and tube insertion. The aim of this study was to compare 
the effectiveness of transoral microdebrider endoscopic-assisted adenoidectomy (TOMEA) and traditional adenoid-
ectomy in the management of children with mild hearing loss due to OME and chronic adenoiditis.
Methods. This prospective, double-blind and controlled study involved 120 consecutive patients aged 4–12 years, who were 
randomised 1:1 to undergo TOMEA or traditional adenoidectomy under general anesthesia. All the patients under-
went a complete otolaryngological examination, including nasopharyngeal fibre endoscopy (NFE), pneumatic otos-
copy, otomicroscopy, tympanometry and supraliminar tonal audiometry, upon enrolment, and three and nine months 
postoperatively.
Results. There were no statistically significant differences in age or gender distribution between the TOMEA group (mean 
age, 4.9±1.1 years; 53.3% males) and the traditional adenoidectomy group (mean age, 5.3±0.9 years; 56.7% 
males). Both procedures led to a significant improvement in choanal patency (P<0.01) and all of the otological and 
audiological parameters (P<0.01) 3 and 9 months postoperatively, although postoperative NFE showed that the 
mean percentage of residual choanal obstruction was significantly less in the TOMEA group (P=0.02). There was no 
significant between-group difference in the percentage of children with tympanic membrane changes, but the postop-
erative prevalence of children with a type B tympanogram was significantly lower in the TOMEA group after 3 
(15.0% vs. 31.7%, P=0.05) and 9 months (18.3% vs. 38.3%, P=0.02), as was the percentage of children with mild 
conductive hearing loss (3.3% vs. 23.3%, P<0.01; and 8.3% vs. 28.3%, P<0.01). 
Conclusion. Although both TOMEA and traditional adenoidectomy are effective in treating children with mild hearing loss 
due to adenoidal hypertrophy and OME, the former achieves the greater reduction in residual adenoidal hypertro-
phy and better audiological outcomes.
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ment, the recommended treatment is still surgery, which may 
take the form of tympanostomy tube insertion or adenoidectomy 
with or without myringotomy or tube insertion [3-5]. Adenoidec-
tomy alone should be considered in children with OME associat-
ed with postnasal obstruction, chronic rhinosinusitis or adenoid-
itis, or those who have previously undergone repeat surgery for 
OME, and has been reported to be most beneficial in children 
aged >3 years regardless of adenoid size [5]. Adenoidal hypertro-
phy and the closeness of the adenoids to the ostium of the Eusta-
chian tube seem to be the most important factors in the patho-
genesis of OME: we have recently found that adenoidal bacterial 
biofilms (recognised causes of OME) are significantly more preva-
lent near the ostium, thus suggesting that the adenoids are a res-
ervoir for biofilm-producing bacteria that can spread through the 
Eustachian tube to colonise the middle ear [6].
 Under these conditions, the aim of surgery in patients with 
OME and adenoidal hypertrophy should be the complete re-
moval of the adenoids not only in order to restore Eustachian 
tube patency, but also to ensure the total eradication of bacterial 
biofilms. Adenoidectomy can be performed using the traditional 
blind approach or an endoscopic-assisted technique that allows 
the more precise and selective removal of lymphoid tissue under 
direct inspection in order to avoid the persistence of small ade-
noidal residues near the ostium of the Eustachian tube.
 The aim of this study was to compare the effectiveness of tran-
soral microdebrider endoscopic-assisted adenoidectomy (TO-
MEA) and traditional adenoidectomy in the management of 
children with mild HL due to OME and chronic adenoiditis.
MATERIALS AND METHODS
Study design and setting
This randomised controlled trial was carried out at the University 
of Milan’s Department of Clinical Sciences and Community 
Health and Department of Physiopathology and Transplantation 
between January 2012 and January 2015. The protocol was ap-
proved by our local Ethics Committee, and written informed con-
sent was obtained from the children’s parents or legal guardians. 
Study subjects
The inclusion criteria were an age of 4–12 years, and the pres-
ence of chronic adenoiditis and OME (middle ear effusion with-
out any sign of acute concomitant middle ear inflammation for 
at least 3 months, documented by means of pneumatic otoscopy 
and timpanometry) with mild conductive HL (mean threshold 
<40 dB at air conduction thresholds of 500, 1,000, 2,000, and 
4,000 Hz) [7]. Chronic adenoiditis was defined as adenoidal hy-
pertrophy (grade III or more according to Cassano’s classifica-
tion, as assessed by means of flexible nasopharyngeal endosco-
py) [8] with ongoing nasopharyngeal inflammation/infection 
(i.e., at least 3 episodes of acute adenoiditis requiring antibiotic 
therapy in 6 months, or at least 4 episodes in 12 months), with 
persistent mucous secretion on the adenoidal surface [9].
 The exclusion criteria were concomitant systemic diseases; 
craniofacial, neuromuscular, immunological, syndromic or de-
fined genetic abnormalities; allergy (documented within the pre-
vious 12 months by positive skin prick tests or radio-allergosor-
bent tests and serum IgE levels); chronic eardrum perforation; 
previous ear surgery or adenoidectomy; moderate-to-severe HL 
(≥40 dB) [7]; and upper respiratory tract infection or antibiotic 
therapy in the previous 14 days.
Assessments
Upon enrolment, and 3 and 9 months postoperatively, all of the 
children underwent pediatric and otolaryngological evaluations, 
including:
• Pneumatic otoscopy and otomicroscopy aimed at evaluating 
the integrity, colour, mobility, position, lightening and translu-
cency of the tympanic membrane, and detecting any signs of 
acute middle ear inflammation. Impaired otoscopy was defined 
as the presence of changes of the tympanic membrane such as 
fibrotic scars, tympanosclerosis, variable opacity, abnormal air-
fluid levels, and retraction pockets.
• Tympanometry, which was used to confirm middle ear effusion 
on the basis of the presence of a type B tympanogram [10].
• Hearing tests (i.e., conditioned play audiometry in children 
aged <5 years or pure tone audiometry in children aged ≥6 
years) conducted by an experienced audiologist [7].
• Flexible nasopharyngeal fibre endoscopy (NFE) (Pentax FNL-
7RP3, Pentax S.r.l., Milan, Italy) performed by two experienced 
otolaryngologists as previously described [11].
 Upon enrolment, the patients were randomised 1:1 to under-
go TOMEA (group A) or traditional adenoidectomy (group B) 
under general anesthesia. All of the surgical procedures were 
performed by two experienced otolaryngologists (PC and LP). 
Surgical techniques
After placing the patients in the Rose position, a Crowe-Davis 
mouth gag was used to splint the mouth open, and two small 
Nélaton catheters were passed through the patient’s nose and 
brought through the mouth in order to retract the soft palate 
and increase the surgical view. 
 In group A, both the 70° endoscope with a video attachment 
and the microdebrider (a serrated, 4-mm diameter Diego-pow-
ered dissector adenoid blade, Gyrus ACMI, Hamburg, Germany) 
were inserted through the oral cavity. Surgical debridement start-
ed from the lowest vegetation on the posterior wall of the phar-
ynx and ended with the upper choanal tissue, including the peri-
tubaric region, and hemostasis was obtained by means of selec-
tive bipolar cauterisation (Fig. 1). 
 In group B, adenoidectomy was performed by inserting a La 
Force adenotome through the mouth and blindly removing the 
nasopharyngeal adenoidal tissue; hemostasis was obtained by 
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placing a package for some minutes. 
 Children were followed up for 9 months. In this interval only 
antibiotic treatment for acute infections were allowed. No treat-
ment for OME was allowed. 
Statistical analysis
The sample size was determined on the basis of published data 
regarding the efficacy of tube insertion in reducing the prevalence 
of middle ear effusion in children with chronic OME [12]. As-
suming that there would be no patients lost to follow-up and a 
standard deviation of 0.20, it was calculated that 60 subjects in 
each group would lead to a beta error margin of 0.20, an alpha 
value of 0.05, and a power of 80%.
 The results are given as arithmetical mean values±standard 
deviation. Age distribution and percentage choanal obstruction 
due to adenoidal hypertrophy before and after surgery were 
tested using the Mann-Whitney nonparametric test, and Fisher 
exact probability test was used to analyse the between-group 
differences in the tympanometric, audiometric and otoscopic 
findings. 
 The statistical analyses were made using the IBM SPSS ver. 
18.0 (IBM Co., Armonk, NY, USA); a P-value of <0.05 was 
considered statistically significant.
RESULTS
There were no statistically significant differences in age or gen-
der distribution between the TOMEA group (mean age, 4.9±1.1 
years; 53.3% males) and the traditional adenoidectomy group 
(mean age, 5.3±0.9 years; 56.7% males) (Table 1).
 Both procedures led to a significant improvement in choanal 
patency (P=0.01) and all of the otological parameters compared 
to the preoperative status, as shown by the significant reduction 
(P<0.01) in the percentage of children with tympanic membrane 
changes, a type B tympanogram, and conductive HL 3 and 9 
Table 1. Demographic and clinical characteristics of patients undergo transoral microdebrider endoscopic-assisted adenoidectomy (group A) 
and traditional adenoidectomy (group B) 
Parameter Group Preop. 3 Months postop. P-value* 9 Months postop. P-value†
Male sex (n=60) A 32 (53.3) - - - -
B 34 (56.7) - - - -
P-value (group A vs. B) NS - - - -
Age (yr) A 4.9±1.1 - - - -
B 5.3±0.9 - - - -
P-value (group A vs. B) NS - - - -
Choanal obstruction (%) A 80.0±15.4 5.5±7.5 <0.01 8.2±6.8 <0.01
B 75.8±14.9 20.3±10.7 <0.01 26.4±7.5 <0.01
P-value (group A vs. B) NS 0.02 0.02
Impaired otoscopy (n=60) A 60 (100) 14 (23.3) <0.01 17 (28.3) <0.01
B 60 (100) 17 (28.3) <0.01 19 (31.7) <0.01
P-value (group A vs. B) NS NS NS
Type B tympanogram (n=60) A 60 (100) 9 (15.0) <0.01 11 (18.3) <0.01
B 60 (100) 19 (31.7) <0.01 23 (28.3) <0.01
P-value (group A vs. B) NS 0.05 0.02
Hearing loss (n=60) A 60 (100) 2 (3.3) <0.01 5 (8.3) <0.01
B 60 (100) 14 (23.3) <0.01 17 (28.3) <0.01
P-value (group A vs. B) NS <0.01 <0.01
Values are presented as number (%) or mean±standard deviation. 
Preop., preoperative; postop., postoperative; NS, nonsignificant.
*Preop. vs. 6 months postop. †Preop. vs. 9 months postop.
Fig. 1. Intraoperative screenshot during transoral microdebrider en-
doscopic-assisted adenoidectomy.
36    Clinical and Experimental Otorhinolaryngology   Vol. 9, No. 1: 33-38, March 2016 
months postoperatively. 
 However, postoperative NFE showed that the postoperative 
mean percentage of residual choanal obstruction was lower in 
group A after both 3 (5.5%±7.5% vs. 20.3%±10.7%, P=0.02) 
and 9 months (8.2%±6.8% vs. 26.4%±7.5%, P=0.02). There 
was no significant between-group difference in the percentage 
of children with tympanic membrane changes 3 (23.3% vs. 
28.3%) and 9 months after surgery (18.3% vs. 31.7%), but the 
percentage of children with a type B tympanogram was signifi-
cantly lower in group A at both timepoints (15.0% vs. 31.7%, 
P=0.05; and 18.3% vs. 38.3%, P=0.02), as was the percentage 
of children with mild conductive HL (3.3% vs. 23.3%, P<0.01; 
and 8.3% vs. 28.3%, P<0.01). 
 Antibiotic treatment for acute respiratory infections was ad-
ministered in few children in 7 out of 60 children in group A 
(11.7%) and in 9 out of 60 children in group B (15.0%) (P=not 
significant). No episodes of acute otitis media were reported. 
DISCUSSION
Adenoidectomy is one of the therapeutic procedures used to 
manage OME, and various surgical techniques have been pro-
posed in attempt to improve clinical outcomes [13,14]. There is 
still a lot of controversy regarding the role of adenoidectomy in 
reducing the incidence of OME. In a recent Cochrane review Van 
den Aardweg et al. [15] reported that is significant benefit of ad-
enoidectomy in the resolution of middle ear effusion in children 
with OME, but the benefit to hearing is small and the effects on 
changes in the tympanic membrane are unknown. Therefore, the 
risks of the surgical procedure should be balanced with the po-
tential benefits in making a decision for or against this surgery. 
In addition to this, the indications of guidelines in different coun-
tries are quite different, ranging from tubes as first choice and 
adenoidectomy as adjuvant only in cases with adenoidal hyper-
trophy [16,17] to adenoidectomy as first choice as suggested by 
Italian Guidelines [18]. In our population miringotomy was not 
performed, not tubes were inserted. We followed the Italian 
Guidelines on the appropriateness of tonsillectomy and adenoid-
ectomy [18] which states that adenoidectomy is indicated in 
children with chronic OME with hypertrophic adenoids obstruct-
ing the Eustachian tube opening or chronic adenoiditis.
 It is well known that both traditional and endoscopic ade-
noidectomy reduce hypertrophic adenoid tissue [13,14] but, to 
the best of our knowledge, their effects on otological and nasal 
outcomes in patients with long-lasting middle ear effusion and 
adenoidal hypertrophy have not been previously compared. The 
aim of this study was to begin filling this gap. 
 Tympanometric evidence of the resolution of OME was ob-
served 9 months postoperatively in most of the patients who un-
derwent TOMEA and in more than 60% of those who under-
went traditional adenoidectomy. In particular, type B tympano-
gram suggesting complete middle ear effusion [10] was more fre-
quently in children belonging to group B compared to those be-
longing to group A (38.3% vs. 18.3%, P=0.02) at the end of fol-
low-up, while type C tympanogram suggesting Eustachian tube 
dysfunction was reported in 12 out of 60 children (20.0%) in 
group A and in 14 out of 60 children (23.3%) in group B (P=not 
significant) 9 months after surgery. These data suggest that ade-
noidectomy globally improve middle ear ventilation and drain-
age, but complete recovery of Eustachian tube function more 
frequently occurred after TOMEA.
 Both procedures also reduced HL as assessed by means of 
audiological tests 3 and 9 months after surgery, but the reduc-
tion was greater in the patients undergoing TOMEA. The superi-
ority of adenoidectomy over other treatments for OME has so 
far been unclear because, although some authors have previous-
ly shown that adenoidectomy is more effective than no adenoid-
ectomy in terms of tympanometric recovery and hearing levels, 
this has not been confirmed by others [19-22]. However, our 
findings provide the first evidence indicating that TOMEA is 
more effective in treating OME-related HL than traditional ade-
noidectomy in the medium term.
 Nasal fibre endoscopy at the end of the follow-up showed 
that TOMEA also led to significantly less mean residual postna-
sal obstruction in comparison with traditional adenoidectomy 
(8% vs. 26%). It has been reported that the endoscopic ade-
noidectomy is effective in reducing long-term postnasal obstruc-
tion due to hypertrophic adenoids [23,24], but the percentages 
of residual postnasal and peritubaric obstruction described after 
traditional adenoidectomy vary; nevertheless, our findings con-
cerning the residual nasopharyngeal obstruction obtained using 
the two surgical techniques are in line with other surgical expe-
riences [23,24]. 
 It is clear that the more complete surgical removal of excess 
nasopharyngeal tissue (especially in the peritubaric area) usually 
allowed by endoscopic surgery reduces the risk of peritubaric 
and velopharyngeal muscle damage [25], and that restoration of 
the patency of the torus tubarius facilitates middle ear drainage 
and ventilation. Ark et al. [26] have found that residual adenoids 
could be detected near at least one torus tubarius in about 
11.4% of their patients who had undergone traditional adenoid-
ectomy, and at the velopharyngeal port in 6.3%, and the partial 
residual obstruction of the torus tubarius caused by this excess 
tissue may explain the persistence of middle ear effusion in such 
patients. Although OME is often caused by impaired Eustachian 
tube patency due to obstructive hypertrophic adenoids, it may 
also be caused by infected adenoids: it has been recently report-
ed that the nasopharynx plays a special role in pediatric pneu-
mococcal colonisation as the primary reservoir of pneumococci 
(which are frequently involved in middle ear inflammation) [27], 
and so adenoidectomy may therefore affect the rate of nasopha-
ryngeal pneumococcal carriage [28]. 
 It has also been recently reported that middle ear effusion, 
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which has historically been considered a sterile condition, is ac-
tually sustained by bacterial species that can only be detected 
by means of polymerase chain reaction and complex electron 
microscopy [29,30]. These bacteria, which are highly resistant to 
traditional antibiotics and immune system activity, quiescently 
colonise the middle ear at a low replication rate, but become pe-
riodically activated and deliver planktonic species known as 
bacterial biofilms. Nasopharyngeal bacterial biofilms are mainly 
produced by classical otopathogens chronically colonise adenoi-
dal surfaces (particularly near the torus tubarius) in children 
with chronic adenoiditis and, during the delivery of the plank-
tonic species responsible for periodic acute exacerbations, “me-
tastasise” through the Eustachian tube to the middle ear, thus 
leading to chronic tubaric and middle ear mucosal infection [29]. 
This may explain the beneficial role of adenoidectomy in the 
therapeutic management of children who have previously un-
dergone repeated myringotomies whose recurrent OME is due 
to the surgical debridement of the adenoidal bacterial biofilm 
reservoir regardless of the degree of obstruction [30]. 
 A statistically significant reduction in the percentage of patients 
with tympanic membrane changes was observed in both groups 
three and nine months postoperatively, with no difference be-
tween the 2 groups. The persistence of impaired otoscopic signs 
such as fibrotic scars and variable opacity in some patients should 
not be considered a negative outcome as it should be related to 
the lasting of the effusion with a following reduced chance of re-
gression. To the best of our knowledge, the long-term effects of 
adenoidectomy on such changes related to long-lasting OME has 
not been previously investigated, and our albeit encouraging re-
sults do not allow us to draw any definite conclusions. 
 These preliminary findings in a small study population suggest 
that both forms of adenoidectomy are effective in managing 
OME in patients with mild HL and adenoid hypertrophy, and 
may indicate that the mild HL associated with OME is reversible. 
However, the audiological and endoscopic results seem to favour 
TOMEA over traditional adenoidectomy, and it should be there-
fore considered in the therapeutic management of young patients 
with OME and adenoidal disease.
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